首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1493600

腔內縫合設備市場 - 全球產業規模、佔有率、趨勢、機會和預測，按應用、最終用戶、地區和競爭細分，2019-2029F

Endoluminal Suturing Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End User, By Region and By Competition, 2019-2029F

出版日期: 2024年05月15日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年，全球腔內縫合器材市場價值為8,472萬美元，預計2029年，預測期內將以11.84%的複合年成長率穩定成長。而設計的專用醫療器材。這些設備用於透過自然孔道或小切口進行的微創外科手術，從而消除了傳統開放性手術的需要。腔內縫合裝置通常與軟性內視鏡結合使用，軟性內視鏡是配備光源和攝影機的薄軟性管。內視鏡可讓外科醫生或內視鏡醫師在手術過程中觀察內部結構並穿過身體的管腔空間。

市場概況
預測期	2025-2029
2023 年市場規模	8472萬美元
2029 年市場規模	16517萬美元
2024-2029 年複合年成長率	11.84%
成長最快的細分市場	減重手術
最大的市場	北美洲

腔內縫合裝置具有用於抓取、操縱和縫合組織的專門機構。這些機構可能包括抓鉗、針驅動器和縫線部署系統，以實現精確的組織逼近和閉合。許多腔內縫合裝置都包含鉸接和可操縱的組件，使外科醫生能夠進入和縫合解剖學上具有挑戰性的位置的組織。鉸接器械提供了更大的靈活性和控制力，增強了外科醫生在有限空間內執行複雜縫合任務的能力。

微創手術技術因其相關優勢而成為全球趨勢，包括減少術後疼痛、縮短住院時間和加速恢復時間。腔內縫合裝置使外科醫生能夠在胃腸道內進行微創手術，從而推動了其採用和利用。腔內縫合技術的不斷進步導致了精度、可操作性和組織閉合能力提高的設備的開發。

機器人輔助、更好的視覺化和人體工學設計等增強功能有助於腔內縫合設備的日益接受和採用。腔內縫合裝置擴大應用於胃腸病學以外的各種醫學專業，包括減重手術、婦科、泌尿科和胸腔外科。這些設備的多功能性及其執行複雜縫合任務的能力有助於其在不同臨床領域的廣泛應用。醫療保健支出的增加，特別是在已開發地區，支持了對腔內縫合設備等先進醫療技術的投資。

主要市場促進因素

技術進步

擴大各專業的應用範圍

對微創手術的偏好日益成長

主要市場挑戰

來自替代技術的競爭

患者選擇和安全問題

主要市場趨勢

內視鏡手術的需求不斷成長

細分市場洞察

應用洞察

最終使用者見解

區域洞察

Global Endoluminal Suturing Devices Market was valued at USD 84.72 million in 2023 and expected to experience a steady growth in the forecast period at a CAGR of 11.84% through 2029. Endoluminal suturing devices are specialized medical instruments designed for suturing or stitching tissues within the body's luminal spaces, such as the gastrointestinal tract, urinary tract, or respiratory tract. These devices are used in minimally invasive surgical procedures performed through natural orifices or small incisions, eliminating the need for traditional open surgery. Endoluminal suturing devices are often used in conjunction with flexible endoscopes, which are thin, flexible tubes equipped with a light source and camera. The endoscope allows surgeons or endoscopists to visualize the internal structures and navigate through the body's luminal spaces during the procedure.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 84.72 Million
Market Size 2029	USD 165.17 Million
CAGR 2024-2029	11.84%
Fastest Growing Segment	Bariatric Surgery
Largest Market	North America

Endoluminal suturing devices feature specialized mechanisms for grasping, manipulating, and suturing tissues. These mechanisms may include grasping forceps, needle drivers, and suture deployment systems that enable precise tissue approximation and closure. Many endoluminal suturing devices incorporate articulating and maneuverable components that allow surgeons to access and suture tissues in anatomically challenging locations. Articulating instruments provide greater dexterity and control, enhancing the surgeon's ability to perform complex suturing tasks within confined spaces.

There is a global trend towards minimally invasive surgical techniques due to their associated benefits, including reduced post-operative pain, shorter hospital stays, and faster recovery times. Endoluminal suturing devices enable surgeons to perform minimally invasive procedures within the gastrointestinal tract, driving their adoption and utilization. Continuous advancements in endoluminal suturing technology have led to the development of devices with improved precision, maneuverability, and tissue closure capabilities.

Enhanced features such as robotic assistance, better visualization, and ergonomic designs contribute to the growing acceptance and adoption of endoluminal suturing devices. Endoluminal suturing devices are increasingly being used in a wide range of medical specialties beyond gastroenterology, including bariatric surgery, gynecology, urology, and thoracic surgery. The versatility of these devices and their ability to perform complex suturing tasks contribute to their expanding applications across different clinical domains. Increasing healthcare expenditure, particularly in developed regions, supports investments in advanced medical technologies such as endoluminal suturing devices.

Key Market Drivers

Technological Advancements

Robotic-assisted endoluminal suturing systems enable surgeons to perform complex suturing tasks with enhanced precision and dexterity. These systems offer greater maneuverability and control, allowing surgeons to access hard-to-reach anatomical locations within the gastrointestinal tract or other body cavities. Endoluminal suturing devices have become increasingly compact and ergonomic, facilitating ease of use and enhancing surgeon comfort during procedures. Miniaturization allows for better maneuverability within confined spaces, enabling more precise tissue approximation and closure. Advanced imaging technologies, such as high-definition cameras and three-dimensional visualization systems, provide surgeons with enhanced visualization of the surgical field during endoluminal procedures. Clearer images help surgeons accurately assess tissue anatomy and guide suturing maneuvers more effectively. Some endoluminal suturing devices incorporate energy delivery systems, such as bipolar or ultrasonic energy, to facilitate tissue dissection, coagulation, and hemostasis during suturing procedures. Integrated energy delivery systems minimize the need for additional instrumentation and streamline the surgical workflow.

Modern endoluminal suturing devices may feature wireless connectivity and data management capabilities, allowing for real-time monitoring of device parameters and surgical metrics. Wireless connectivity enables seamless integration with electronic health record systems and facilitates remote monitoring and collaboration during procedures. Advanced endoluminal suturing systems may incorporate tactile feedback mechanisms and force sensing technologies to provide surgeons with tactile information and feedback on tissue characteristics and suture tension. Real-time feedback helps surgeons adjust their suturing technique and optimize tissue approximation. Some endoluminal suturing devices feature disposable components and single-use designs, reducing the risk of cross-contamination and infection transmission. Single-use devices eliminate the need for reprocessing and sterilization, streamlining the surgical workflow and enhancing patient safety. Innovative endoluminal suturing systems allow surgeons to customize suturing patterns and techniques based on specific procedural requirements and patient anatomy. Adjustable parameters such as stitch length, depth, and spacing enable tailored approaches to tissue closure and reinforcement. This factor will help in the development of the Global Endoluminal Suturing Devices Market.

Expanding Applications in Various Specialties

Endoluminal suturing devices are extensively used in gastroenterology for procedures such as closure of perforations, management of gastrointestinal bleeding, treatment of fistulas, and removal of polyps. These devices enable gastroenterologists to perform minimally invasive interventions with greater precision and control, reducing the need for open surgery and shortening recovery times. In bariatric surgery, endoluminal suturing devices are employed for procedures like gastric plication, revision surgeries, and management of postoperative complications. These devices facilitate the creation of durable sutures and tissue approximation within the gastrointestinal tract, contributing to successful weight loss outcomes and improved metabolic health in obese patients.

Endoluminal suturing devices find applications in gynecological procedures such as laparoscopic myomectomy, ovarian cystectomy, and uterine suspension surgeries. These devices enable gynecologists to perform intricate suturing tasks with minimal tissue trauma, reducing the risk of postoperative complications and preserving reproductive function in patients. Endoluminal suturing devices are utilized in urological procedures such as vesicourethral anastomosis, bladder neck reconstruction, and treatment of urinary fistulas. These devices facilitate precise tissue approximation and closure within the urinary tract, enabling urologists to achieve optimal surgical outcomes while minimizing the risk of urinary incontinence and other complications.

In thoracic surgery, endoluminal suturing devices are employed for procedures such as closure of bronchopleural fistulas, management of esophageal leaks, and treatment of mediastinal masses. These devices enable thoracic surgeons to perform minimally invasive interventions with improved accuracy and efficiency, resulting in reduced postoperative morbidity and enhanced patient recovery. Endoluminal suturing devices are utilized in colorectal surgery for procedures such as closure of colorectal anastomoses, treatment of rectal prolapse, and management of diverticular disease. These devices facilitate secure tissue approximation and reinforcement, reducing the risk of anastomotic leaks and promoting faster healing in colorectal surgical patients.

In ENT surgery, endoluminal suturing devices are used for procedures such as closure of palatal defects, treatment of velopharyngeal insufficiency, and management of laryngeal injuries. These devices enable ENT surgeons to perform delicate suturing tasks with precision, optimizing functional outcomes and minimizing postoperative complications. This factor will pace up the demand of the Global Endoluminal Suturing Devices Market.

Growing Preference for Minimally Invasive Surgeries

Minimally invasive surgeries, including those facilitated by endoluminal suturing devices, involve smaller incisions or natural orifices compared to traditional open surgeries. This leads to reduced surgical trauma, less blood loss, and minimal disruption of surrounding tissues, resulting in faster recovery times and reduced postoperative pain for patients. Minimally invasive surgeries performed with endoluminal suturing devices typically require shorter hospital stays compared to open surgeries. This is advantageous for patients as it allows them to return to their normal activities sooner and reduces the burden on healthcare facilities.

Minimally invasive surgeries using endoluminal suturing devices are associated with lower rates of surgical complications such as wound infections, hernias, and surgical site complications. The reduced risk of complications enhances patient safety and improves overall surgical outcomes. Minimally invasive surgeries leave smaller scars and have better cosmetic outcomes compared to traditional open surgeries. This is particularly important for patients undergoing aesthetic procedures or surgeries in cosmetically sensitive areas.

Endoluminal suturing devices enable surgeons to perform precise suturing and tissue approximation within body cavities and anatomically challenging locations. The devices offer greater control and maneuverability, allowing surgeons to achieve optimal surgical outcomes even in confined spaces. Minimally invasive surgeries using endoluminal suturing devices are associated with faster recovery times compared to open surgeries. Patients experience less postoperative pain, reduced risk of infection, and quicker return to normal activities, leading to improved patient satisfaction and quality of life.

Endoluminal suturing devices enable surgeons to perform a wide range of minimally invasive procedures across various medical specialties, including gastroenterology, urology, gynecology, and thoracic surgery. The versatility of these devices expands the scope of minimally invasive surgery and provides patients with access to advanced treatment options. Minimally invasive surgeries using endoluminal suturing devices can result in cost savings for healthcare systems by reducing hospitalization costs, operating room time, and postoperative care requirements. This makes minimally invasive approaches more economically viable and sustainable in the long term. This factor will accelerate the demand of the Global Endoluminal Suturing Devices Market.

Key Market Challenges

Competition from Alternative Technologies

Surgical staplers are a primary alternative to endoluminal suturing devices for tissue approximation and closure. Staplers offer a faster and more automated approach to tissue closure compared to manual suturing with endoluminal devices. They are commonly used in open and laparoscopic surgeries, particularly in procedures involving thicker tissues or larger vessels. Hemostatic clips and ligating devices provide a simple and effective means of vessel ligation and tissue closure in endoscopic and laparoscopic procedures. These devices are often used in conjunction with endoluminal suturing devices or as standalone alternatives, depending on the specific clinical requirements and anatomical considerations. Tissue adhesives and sealants offer an alternative approach to tissue closure and hemostasis in certain surgical scenarios. These products provide rapid adhesion and sealing of tissue surfaces without the need for sutures or staples.

While they may not be suitable for all applications, tissue adhesives and sealants compete with endoluminal suturing devices in specific clinical contexts. Advanced hemostatic agents, such as absorbable hemostatic sponges and fibrin sealants, are used to control bleeding and promote hemostasis during surgical procedures. These agents may be employed as adjuncts to endoluminal suturing devices or as standalone alternatives in situations where conventional suturing is impractical or ineffective. Energy-based devices, including electrosurgical instruments, ultrasonic dissectors, and radiofrequency ablation devices, offer alternative modalities for tissue dissection, coagulation, and hemostasis. These devices may complement endoluminal suturing devices in certain procedures or provide alternative solutions for tissue management and hemostasis.

Patient Selection and Safety Concerns

Identifying appropriate candidates for endoluminal suturing procedures requires careful consideration of patient demographics, medical history, anatomical factors, and procedural risks. Patient selection criteria may vary depending on the specific indication and anatomical site targeted for treatment, making it challenging for healthcare providers to standardize patient selection protocols across different clinical scenarios. Patients undergoing endoluminal suturing procedures may present with a wide range of anatomical variations and comorbidities that influence procedural feasibility and safety. Anatomical factors such as tissue laxity, fibrosis, and scar tissue formation can pose technical challenges during suturing and increase the risk of procedural complications.

Comorbidities such as obesity, diabetes, and cardiovascular disease may exacerbate surgical risks and impact patient outcomes. Endoluminal suturing procedures carry inherent risks of tissue perforation, bleeding, and other procedural complications. The proximity of vital structures, such as blood vessels and nerves, within the gastrointestinal tract and other anatomical regions increases the risk of inadvertent injury during suturing maneuvers. Ensuring adequate hemostasis and tissue approximation while minimizing the risk of complications requires precise surgical technique and real-time monitoring of procedural endpoints. Performing endoluminal suturing procedures requires specialized training and expertise to ensure procedural safety and efficacy.

Surgeons and healthcare providers must possess proficiency in endoscopic techniques, suturing principles, and device manipulation to mitigate the risk of adverse events and optimize patient outcomes. Inadequate training and lack of standardized education programs may contribute to variations in procedural outcomes and compromise patient safety. Endoluminal suturing procedures are associated with postoperative complications such as wound dehiscence, infection, and recurrence of underlying pathology. Ensuring comprehensive postoperative care, including close monitoring of patients for signs of complications and timely intervention, when necessary, is essential for minimizing adverse outcomes and optimizing long-term surgical outcomes.

Key Market Trends

Rising Demand for Endoscopic Procedures

Technological advancements in endoscopic imaging, instrumentation, and surgical techniques have expanded the scope and feasibility of endoscopic procedures across various medical specialties. High-definition imaging systems, flexible endoscopes, and innovative surgical instruments enable surgeons and endoscopists to perform complex interventions within the gastrointestinal tract and other anatomical regions with greater precision and control. Endoscopic procedures serve both diagnostic and therapeutic purposes, allowing healthcare providers to visualize, biopsy, and treat a wide range of gastrointestinal and other medical conditions. Endoluminal suturing devices play a crucial role in therapeutic endoscopy by facilitating tissue approximation, closure of defects, and management of complications such as gastrointestinal bleeding, perforations, and fistulas.

The indications for endoscopic procedures continue to expand beyond traditional diagnostic and therapeutic interventions to include emerging applications such as obesity management, metabolic surgery, and natural orifice transluminal endoscopic surgery (NOTES). Endoluminal suturing devices enable surgeons to perform increasingly complex procedures through flexible endoscopes, offering minimally invasive alternatives to conventional surgical approaches. The aging population and the increasing prevalence of chronic diseases such as gastrointestinal disorders, obesity, and colorectal cancer drive the demand for endoscopic procedures for diagnosis, treatment, and surveillance. Endoluminal suturing devices play a crucial role in the management of these conditions by enabling minimally invasive interventions that minimize patient morbidity and improve quality of life.

Segmental Insights

Application Insights

The Gastrointestinal Surgery segment is projected to dominate the segment in the Global Endoluminal Suturing Devices Market during the forecast period. Gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), gastrointestinal bleeding, and colorectal cancer, are prevalent worldwide. The increasing incidence of these conditions, often requiring surgical intervention, drives the demand for endoluminal suturing devices designed specifically for gastrointestinal surgeries. There is a growing preference for minimally invasive surgical techniques in gastrointestinal surgery due to their associated benefits, including reduced post-operative pain, shorter hospital stays, and faster recovery times.

Endoluminal suturing devices enable surgeons to perform minimally invasive procedures within the gastrointestinal tract, facilitating tissue approximation and closure without the need for traditional open surgery. Technological advancements in endoluminal surgery have expanded the scope and feasibility of gastrointestinal procedures using suturing devices. Modern endoluminal suturing devices offer improved precision, maneuverability, and tissue closure capabilities, making them well-suited for a wide range of gastrointestinal surgeries. Endoluminal surgery techniques are increasingly being utilized to address a variety of gastrointestinal conditions beyond traditional indications. This includes procedures such as endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and closure of perforations or fistulas. The versatility of endoluminal suturing devices allows for their application across a spectrum of gastrointestinal surgeries.

End User Insights

The hospitals segment is projected to experience rapid growth in the Global Endoluminal Suturing Devices Market during the forecast period. Hospitals serve as primary centers for surgical procedures, including minimally invasive endoluminal surgeries. As the volume of surgical procedures continues to rise, driven by factors such as the aging population and the prevalence of chronic diseases, the demand for endoluminal suturing devices within hospitals is expected to increase significantly. The development of advanced endoluminal suturing devices with improved precision, maneuverability, and ease of use makes them well-suited for use in hospital settings. Hospitals are often equipped with the necessary infrastructure and expertise to adopt and utilize these cutting-edge technologies effectively. Hospitals offer comprehensive healthcare services, including diagnostic, therapeutic, and surgical interventions.

Endoluminal suturing devices complement other medical technologies and procedures available in hospitals, allowing for a more integrated approach to patient care. Hospitals provide centralized patient care facilities, making them convenient locations for performing complex endoluminal surgical procedures. Patients can access a wide range of medical specialists and support services within the hospital setting, enhancing the overall quality and continuity of care. Hospitals typically serve a larger patient population compared to other healthcare settings such as clinics or ambulatory surgical centers. The higher patient volume translates to increased demand for endoluminal suturing devices to meet the growing needs of patients requiring surgical interventions.

Regional Insights

North America emerged as the dominant player in the Global Endoluminal Suturing Devices Market in 2023. North America boasts a well-developed healthcare infrastructure, with access to state-of-the-art medical facilities and advanced surgical techniques. This infrastructure supports the adoption of innovative medical devices like endoluminal suturing devices. The region has one of the highest healthcare expenditures globally, allowing for greater investment in medical technologies and procedures. Healthcare providers in North America have the financial resources to acquire and utilize endoluminal suturing devices in clinical practice.

North America is home to many leading medical device companies and research institutions that focus on developing cutting-edge healthcare technologies. The region's emphasis on research and development contributes to the continuous innovation and advancement of endoluminal suturing devices. There is a growing trend towards minimally invasive surgical techniques in North America. Endoluminal suturing devices play a crucial role in these procedures, as they enable surgeons to perform intricate suturing tasks through small incisions or natural orifices, leading to reduced patient trauma and faster recovery times.

Key Market Players

Apollo Endosurgery, Inc.

Johnson & Johnson

Medtronic Plc

Cook Group Incorporated

USGI Medical, Inc

Ovesco Endoscopy AG

Endo Tools Therapeutics S.A

ErgoSuture Corp.

Sutrue Ltd.

Report Scope:

In this report, the Global Endoluminal Suturing Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Endoluminal Suturing Devices Market, By Application:

Bariatric Surgery Gastrointestinal Surgery Gastroesophageal Reflux Disease Surgery Others

Endoluminal Suturing Devices Market, By End User:

Hospitals Ambulatory Surgical Clinics Others

Endoluminal Suturing Devices Market, By Region:

North America

United States

Canada

Mexico

Europe

Germany

United Kingdom

France

Italy

Spain

Asia-Pacific

China

Japan

India

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Endoluminal Suturing Devices Market.

Available Customizations:

Global Endoluminal Suturing Devices market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Endoluminal Suturing Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Bariatric Surgery, Gastrointestinal Surgery, Gastroesophageal Reflux Disease Surgery, Others)
- 5.2.2. By End User (Hospitals, Ambulatory Surgical Clinics, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2023)
5.3. Market Map

6. North America Endoluminal Suturing Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By End User
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Endoluminal Suturing Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
    - 6.3.1.2.2. By End User
- 6.3.2. Canada Endoluminal Suturing Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
    - 6.3.2.2.2. By End User
- 6.3.3. Mexico Endoluminal Suturing Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application
    - 6.3.3.2.2. By End User

7. Europe Endoluminal Suturing Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By End User
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Endoluminal Suturing Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
    - 7.3.1.2.2. By End User
- 7.3.2. United Kingdom Endoluminal Suturing Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
    - 7.3.2.2.2. By End User
- 7.3.3. Italy Endoluminal Suturing Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Application
    - 7.3.3.2.2. By End User
- 7.3.4. France Endoluminal Suturing Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
    - 7.3.4.2.2. By End User
- 7.3.5. Spain Endoluminal Suturing Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application
    - 7.3.5.2.2. By End User

8. Asia-Pacific Endoluminal Suturing Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By End User
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Endoluminal Suturing Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
    - 8.3.1.2.2. By End User
- 8.3.2. India Endoluminal Suturing Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
    - 8.3.2.2.2. By End User
- 8.3.3. Japan Endoluminal Suturing Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
    - 8.3.3.2.2. By End User
- 8.3.4. South Korea Endoluminal Suturing Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
    - 8.3.4.2.2. By End User
- 8.3.5. Australia Endoluminal Suturing Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application
    - 8.3.5.2.2. By End User

9. South America Endoluminal Suturing Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By End User
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Endoluminal Suturing Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
    - 9.3.1.2.2. By End User
- 9.3.2. Argentina Endoluminal Suturing Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
    - 9.3.2.2.2. By End User
- 9.3.3. Colombia Endoluminal Suturing Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application
    - 9.3.3.2.2. By End User

10. Middle East and Africa Endoluminal Suturing Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By End User
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Endoluminal Suturing Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
    - 10.3.1.2.2. By End User
- 10.3.2. Saudi Arabia Endoluminal Suturing Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
    - 10.3.2.2.2. By End User
- 10.3.3. UAE Endoluminal Suturing Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application
    - 10.3.3.2.2. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product

14. Competitive Landscape

14.1. Apollo Endosurgery, Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Johnson & Johnson
14.3. Medtronic Plc
14.4. Cook Group Incorporated
14.5. USGI Medical, Inc
14.6. Ovesco Endoscopy AG
14.7. Endo Tools Therapeutics S.A
14.8. ErgoSuture Corp.
14.9. Sutrue Ltd.